Significance of serum procalcitonin as biomarker for detection of bacterial peritonitis: A systematic review and meta-analysis

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Yang, Shi kun ^a   Xiao, Li ^a   Zhang, Hao ^a   Xu, Xiao xuan ^a   Song, Pan ai ^a   Liu, Fu you ^a   Sun, Lin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Diagnosis; Meta analysis; Peritonitis; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

AREA UNDER THE CURVE; ARTICLE; BACTERIAL PERITONITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HORMONE BLOOD LEVEL; HUMAN; META ANALYSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ALGORITHM; BACTERIAL INFECTIONS; BLOOD; CHINA; PERITONITIS; REPRODUCIBILITY; RISK;

ALGORITHMS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHINA; HUMANS; ODDS RATIO; PERITONITIS; PROTEIN PRECURSORS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84910083787     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-452     Document Type: Article

References (51)

1. Ordonez CA, Puyana JC. Management of peritonitis in the critically ill patient. Surg Clin North Am 2006, 86(6):1323-1349.
2. Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit Dial Int 2009, 29(3):297-302.
3. Bernardi M. Spontaneous bacterial peritonitis: from pathophysiology to prevention. Intern Emerg Med 2010, 5(Suppl 1):S37-S44.
4. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013, 13(5):426-435.
5. Irwin AD, Carrol ED. Procalcitonin. Arch Dis Child Educ Pract Ed 2011, 96(6):228-233.
6. Dou YH, Du JK, Liu HL, Shong XD. The role of procalcitonin in the identification of invasive fungal infection-a systemic review and meta-analysis. Diagn Microbiol Infect Dis 2013, 76(4):464-469.
7. Su DH, Zhuo C, Liao K, Cheng WB, Cheng H, Zhao XF. Value of serum procalcitonin levels in predicting spontaneous bacterial peritonitis. Hepatogastroenterology 2013, 60(124):641-646.
8. Rosman AS, Korsten MA. Application of summary receiver operating characteristics (sROC) analysis to diagnostic clinical testing. Adv Med Sci 2007, 52:76-82.
9. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283(15):2008-2012.
10. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25.
11. Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 2005, 16(1):73-81.
12. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 2002, 21(4):589-624.
13. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005, 58(10):982-990.
14. Chappell FM, Raab GM, Wardlaw JM. When are summary ROC curves appropriate for diagnostic meta-analyses?. Stat Med 2009, 28(21):2653-2668.
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558.
16. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005, 58(9):882-893.
17. Guz G, Colak B, Hizel K, Reis KA, Erten Y, Bali M, Sindel S. Procalcitonin and conventional markers of inflammation in peritoneal dialysis patients and peritonitis. Perit Dial Int 2006, 26(2):240-248.
18. Lam MF, Leung JC, Lam CW, Tse KC, Lo WK, Lui SL, Chan TM, Tam S, Lai KN. Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis. Perit Dial Int 2008, 28(4):377-384.
19. Yilmaz FM, Yilmaz G, Akay H, Duranay M, Yucel D. Evaluation of a card test for procalcitonin in continuous ambulatory peritoneal dialysis peritonitis. Ann Clin Biochem 2007, 44(Pt 5):482-484.
20. Özturk R, Yilmaz GR, Bulut C, Parpucu H, Kinikli S, Duranay M, Demiröz AP. Assessment of procalcitonin and other inflammatory markers in peritoneal dialysis-related peritonitis. Turk J Med Sci 2010, 40(20):199-206.
21. Cekin Y, Cekin AH, Duman A, Yilmaz U, Yesil B, Yolcular BO. The role of serum procalcitonin levels in predicting ascitic fluid infection in hospitalized cirrhotic and non-cirrhotic patients. Int J Med Sci 2013, 10(10):1367-1374.
22. Spahr L, Morard I, Hadengue A, Vadas L, Pugin J. Procalcitonin is not an accurate marker of spontaneous bacterial peritonitis in patients with cirrhosis. Hepatogastroenterology 2001, 48(38):502-505.
23. Viallon A, Zeni F, Pouzet V, Lambert C, Quenet S, Aubert G, Guyomarch S, Tardy B, Bertrand JC. Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive Care Med 2000, 26(8):1082-1088.
24. Yuan LY, Ke ZQ, Wang M, Li Y. Procalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis B. Ann Lab Med 2013, 33(6):449-454.
25. Connert S, Stremmel W, Elsing C. Procalcitonin is a valid marker of infection in decompensated cirrhosis. Z Gastroenterol 2003, 41(2):165-170.
26. Zhang W, Zhang SL, Wang HB. Clinical value of detection of plasma procalcitonin, TNFa{cyrillic} and IL-6 in liver cirrhotic patients. Chin J Infect Dis 2003, 21(1):47-49.
27. Lai JL. Clinical significance of the combination detection of Procalcitonin and C-reactive protein in the cirrhosis patients complicated with spontaneous bacterial peritonitis. Fujian Med J 2013, 35(1):65-67.
28. Yang CH, Shen Y, Fan X. The role of ascitic procalcitonin, TNFa{cyrillic} and LPS in predicting spontaneous bacterial peritonitis in cirrhotic patients. Modern Practical Medicine 2007, 19(3):208-210.
29. Zhang W, Gao ZQ, Zhang SL. Clinical significance of detection of plasma and ascitic procalcitonin in cirrhotic patients with spontaneous bacterial peritonitis. Chin J Clini Hepatol 2004, 20(3):174-176.
30. Zhang Y, Zhang ZG. Clinical value of procalcitonin and C-reactive protein test in liver cirrhotic patients with spontaneous bacterial peritonitis. Clinical Focus 2010, 25(8):665-669.
31. Liu JC, Wang ZS, Xue X, Gu JM. Diagonosis value of serum procalcitonin in cirrhotic patients with sponaneous bacterial peritonitis. J Dalian Med Univ 2006, 3(28):201-203.
32. Liu ZJ, Cai HD, Zhang YH. Alteration of serum procalcitonin levels in liver cirrhosis patients complicated with spontaneous bacterial peritonitis. Chin J Exp Clin Infect Dis 2012, 6(3):238-241.
33. Wu J, Jiang F, Zeng T, Xu H, Lei Y, Zhong S, Zhou Z, Ren H. Role of serum procalcitonin assay for diagnosis of spontaneous bacterial peritonitis in end-stage liver diseases. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2014, 36(1):37-41.
34. Xie F, Liu ZX, Chen L. Clinical significance of detecting levels of serum and ascitic PCT in patients with liver cirrhosis complicating spontaneous bacterial peritonitis. Int J Lab Med 2014, 35(5):525-527.
35. Chesney RW, McCarron DM, Haddad JG, Hawker CD, DiBella FP, Chesney PJ, Davis JP. Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome. J Lab Clin Med 1983, 101(4):576-585.
36. Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res 2000, 49(Suppl 1):S57-S61.
37. Morgenthaler NG, Struck J, Chancerelle Y, Weglohner W, Agay D, Bohuon C, Suarez-Domenech V, Bergmann A, Muller B. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm Metab Res 2003, 35(5):290-295.
38. Yu CW, Juan LI, Hsu SC, Chen CK, Wu CW, Lee CC, Wu JY. Role of procalcitonin in the diagnosis of infective endocarditis: a meta-analysis. Am J Emerg Med 2013, 31(6):935-941.
39. Shen CJ, Wu MS, Lin KH, Lin WL, Chen HC, Wu JY, Lee MC, Lee CC. The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis. Eur J Clin Microbiol Infect Dis 2013, 32(6):807-814.
40. Akoh JA. Peritoneal dialysis associated infections: An update on diagnosis and management. World J Nephrol 2012, 1(4):106-122.
41. Song Y, Wu J, Yan H, Chen J. Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant 2012, 27(4):1639-1644.
42. Meisner M, Lohs T, Huettemann E, Schmidt J, Hueller M, Reinhart K. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 2001, 18(2):79-87.
43. Opatrna S, Klaboch J, Opatrny K, Holubec L, Tomsu M, Sefrna F, Topolcan O. Procalcitonin levels in peritoneal dialysis patients. Perit Dial Int 2005, 25(5):470-472.
44. Lu XL, Xiao ZH, Yang MY, Zhu YM. Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: a systematic review and meta-analysis. Nephrol Dial Transplant 2013, 28(1):122-129.
45. Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut 2012, 61(2):297-310.
46. Bota DP, Van Nuffelen M, Zakariah AN, Vincent JL. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005, 146(6):347-351.
47. Basturk T, Koc Y, Unsal A, Ahbap E, Sakaci T, Yildiz I, Kayabasi H, Sevinc M, Kose S, Arar A. Fungal peritonitis in peritoneal dialysis: a 10 year retrospective analysis in a single center. Eur Rev Med Pharmacol Sci 2012, 16(12):1696-1700.
48. Hwang SY, Yu SJ, Lee JH, Kim JS, Yoon JW, Kim YJ, Yoon JH, Kim EC, Lee HS. Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis. Eur J Clin Microbiol Infect Dis 2014, 33(2):259-264.
49. Petrikkos GL, Christofilopoulou SA, Tentolouris NK, Charvalos EA, Kosmidis CJ, Daikos GL. Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections. Eur J Clin Microbiol Infect Dis 2005, 24(4):272-275.
50. Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club J Hepatol 2000, 32(1):142-153.
51. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Systematic reviews of diagnostic test accuracy. Ann Intern Med 2008, 149(12):889-897.